Women may have more adverse events with left atrial appendage occlusion devices than men

Left atrial appendage occlusion (LAAO) devices on the market include Abbott’s Amplatzer Amulet (left) and Boston Scientific’s Watchman (right). [Images courtesy of Abbott and Boston Scientific]Women appear more likely than men to experience adverse events or lengthened hospital stays from left atrial appendage occlusion (LAAO) devices, the FDA announced today.

In a letter to health care providers, the FDA said researchers have yet to determine the reason for the difference — and that it is working with device makers to understand the cause.

Get the full story on our sister site Medical Design & Outsourcing. 

Read more
  • 0